Live Chat

Live Chat

Blood culture media

Decrease time to detection during the analytical phase with a full spectrum of blood culture media solutions.

The combination of the BD BACTEC Plus aerobic and Lytic anaerobic media allows for improved time to detect and recovery of both aerobic and anaerobic organisms.1

The BD BACTEC bottle portfolio provides a full line of blood culture media developed specifically for the detection of aerobes, anaerobes, yeast, fungi and mycobacteria to help improve time to detect and organism recovery2 from both adult and pediatric patients.

Globally, over a third of patients hospitalized with sepsis may die prior to hospital discharge. Best practice recommends collecting at least two sets of blood cultures prior to antimicrobial therapy to help improve organism recovery.3

Placeholder

BD BACTEC Lytic Anaerobic medium

BD BACTEC Lytic Anaerobic medium lyses blood cells, releasing intracellular organisms.

Placeholder

BD BACTEC Plus Aerobic medium

BD BACTEC Plus Aerobic medium effectively neutralizes a wide range of antimicrobials.

Placeholder

BD BACTEC Plus Anaerobic medium

BD BACTEC Plus Anaerobic medium supports the growth of anaerobic organisms and contains resins to neutralize antibiotics.

Placeholder

BD BACTEC Standard Aerobic medium

BD BACTEC Standard Aerobic medium is an enriched soybean-casein digest broth for recovery of aerobic organisms.

Placeholder

BD BACTEC Standard Anaerobic medium

BD BACTEC Standard Anaerobic medium is designed to recover anaerobic microorganisms from blood.

Placeholder

BD Synapsys microbiology informatics solution

BD Synapsys informatics assists with trending and tracking blood culture collection best practices for continued laboratory improvement.


References
  1. Rohner P et al. J Clin Microbiol. 1997; 35(10):2634-2638.
  2. Hawkins R. Managing the pre- and post-analytical phases of the total testing process. Ann Lab Med. 2012;32:5-16.
  3. Vincent JL et al. Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit. Lancet Respir Med. 2014;2:380-386.

This site uses cookies. If you click accept cookies then all cookies will be written. Please review our cookies policy and configure your cookies for your experience.